Clinical Trial Update: HEMOTAG® Assessment for Short-term Outcomes of Heart Failure [NA]

View source ↗

Summary

Aventusoft, LLC is conducting a clinical trial evaluating HEMOTAG for short-term outcomes in heart failure. The study is currently recruiting with no results re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Drugs mentioned

• hemoTAG

Snippet

Sponsor: Aventusoft, LLC. | Conditions: Heart Failure (HF) | NA | Status: RECRUITING